Clinical practice guidelines for congenital hyperinsulinism

Tohru Yorifuji, Reiko Horikawa, Tomonobu Hasegawa, Masanori Adachi, Shun Soneda, Masanori Minagawa, Shinobu Ida, Takeo Yonekura, Yoshiaki Kinoshita, Yutaka Kanamori, Hiroaki Kitagawa, Masato Shinkai, Hideyuki Sasaki, Masaki Nio

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Congenital hyperinsulinism is a rare condition, and following recent advances in diagnosis and treatment, it was considered necessary to formulate evidence-based clinical practice guidelines reflecting the most recent progress, to guide the practice of neonatologists, pediatric endocrinologists, general pediatricians, and pediatric surgeons. These guidelines cover a range of aspects, including general features of congenital hyperinsulinism, diagnostic criteria and tools for diagnosis, first- and second-line medical treatment, criteria for and details of surgical treatment, and future perspectives. These guidelines were generated as a collaborative effort between The Japanese Society for Pediatric Endocrinology and The Japanese Society of Pediatric Surgeons, and followed the official procedures of guideline generation to identify important clinical questions, perform a systematic literature review (April 2016), assess the evidence level of each paper, formulate the guidelines, and obtain public comments.

Original languageEnglish
Pages (from-to)127-152
Number of pages26
JournalClinical Pediatric Endocrinology
Volume26
Issue number3
DOIs
Publication statusPublished - 2017

Fingerprint

Congenital Hyperinsulinism
Practice Guidelines
Guidelines
Pediatrics
Endocrinology
Evidence-Based Practice
Therapeutics

Keywords

  • Congenital hyperinsulinism
  • Guidelines
  • Hypoglycemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Yorifuji, T., Horikawa, R., Hasegawa, T., Adachi, M., Soneda, S., Minagawa, M., ... Nio, M. (2017). Clinical practice guidelines for congenital hyperinsulinism. Clinical Pediatric Endocrinology, 26(3), 127-152. https://doi.org/10.1297/cpe.26.127

Clinical practice guidelines for congenital hyperinsulinism. / Yorifuji, Tohru; Horikawa, Reiko; Hasegawa, Tomonobu; Adachi, Masanori; Soneda, Shun; Minagawa, Masanori; Ida, Shinobu; Yonekura, Takeo; Kinoshita, Yoshiaki; Kanamori, Yutaka; Kitagawa, Hiroaki; Shinkai, Masato; Sasaki, Hideyuki; Nio, Masaki.

In: Clinical Pediatric Endocrinology, Vol. 26, No. 3, 2017, p. 127-152.

Research output: Contribution to journalArticle

Yorifuji, T, Horikawa, R, Hasegawa, T, Adachi, M, Soneda, S, Minagawa, M, Ida, S, Yonekura, T, Kinoshita, Y, Kanamori, Y, Kitagawa, H, Shinkai, M, Sasaki, H & Nio, M 2017, 'Clinical practice guidelines for congenital hyperinsulinism', Clinical Pediatric Endocrinology, vol. 26, no. 3, pp. 127-152. https://doi.org/10.1297/cpe.26.127
Yorifuji, Tohru ; Horikawa, Reiko ; Hasegawa, Tomonobu ; Adachi, Masanori ; Soneda, Shun ; Minagawa, Masanori ; Ida, Shinobu ; Yonekura, Takeo ; Kinoshita, Yoshiaki ; Kanamori, Yutaka ; Kitagawa, Hiroaki ; Shinkai, Masato ; Sasaki, Hideyuki ; Nio, Masaki. / Clinical practice guidelines for congenital hyperinsulinism. In: Clinical Pediatric Endocrinology. 2017 ; Vol. 26, No. 3. pp. 127-152.
@article{b475675b43e64d689280bd822bcc8b52,
title = "Clinical practice guidelines for congenital hyperinsulinism",
abstract = "Congenital hyperinsulinism is a rare condition, and following recent advances in diagnosis and treatment, it was considered necessary to formulate evidence-based clinical practice guidelines reflecting the most recent progress, to guide the practice of neonatologists, pediatric endocrinologists, general pediatricians, and pediatric surgeons. These guidelines cover a range of aspects, including general features of congenital hyperinsulinism, diagnostic criteria and tools for diagnosis, first- and second-line medical treatment, criteria for and details of surgical treatment, and future perspectives. These guidelines were generated as a collaborative effort between The Japanese Society for Pediatric Endocrinology and The Japanese Society of Pediatric Surgeons, and followed the official procedures of guideline generation to identify important clinical questions, perform a systematic literature review (April 2016), assess the evidence level of each paper, formulate the guidelines, and obtain public comments.",
keywords = "Congenital hyperinsulinism, Guidelines, Hypoglycemia",
author = "Tohru Yorifuji and Reiko Horikawa and Tomonobu Hasegawa and Masanori Adachi and Shun Soneda and Masanori Minagawa and Shinobu Ida and Takeo Yonekura and Yoshiaki Kinoshita and Yutaka Kanamori and Hiroaki Kitagawa and Masato Shinkai and Hideyuki Sasaki and Masaki Nio",
year = "2017",
doi = "10.1297/cpe.26.127",
language = "English",
volume = "26",
pages = "127--152",
journal = "Clinical Pediatric Endocrinology",
issn = "0918-5739",
publisher = "Jeff Corporation Co. Ltd",
number = "3",

}

TY - JOUR

T1 - Clinical practice guidelines for congenital hyperinsulinism

AU - Yorifuji, Tohru

AU - Horikawa, Reiko

AU - Hasegawa, Tomonobu

AU - Adachi, Masanori

AU - Soneda, Shun

AU - Minagawa, Masanori

AU - Ida, Shinobu

AU - Yonekura, Takeo

AU - Kinoshita, Yoshiaki

AU - Kanamori, Yutaka

AU - Kitagawa, Hiroaki

AU - Shinkai, Masato

AU - Sasaki, Hideyuki

AU - Nio, Masaki

PY - 2017

Y1 - 2017

N2 - Congenital hyperinsulinism is a rare condition, and following recent advances in diagnosis and treatment, it was considered necessary to formulate evidence-based clinical practice guidelines reflecting the most recent progress, to guide the practice of neonatologists, pediatric endocrinologists, general pediatricians, and pediatric surgeons. These guidelines cover a range of aspects, including general features of congenital hyperinsulinism, diagnostic criteria and tools for diagnosis, first- and second-line medical treatment, criteria for and details of surgical treatment, and future perspectives. These guidelines were generated as a collaborative effort between The Japanese Society for Pediatric Endocrinology and The Japanese Society of Pediatric Surgeons, and followed the official procedures of guideline generation to identify important clinical questions, perform a systematic literature review (April 2016), assess the evidence level of each paper, formulate the guidelines, and obtain public comments.

AB - Congenital hyperinsulinism is a rare condition, and following recent advances in diagnosis and treatment, it was considered necessary to formulate evidence-based clinical practice guidelines reflecting the most recent progress, to guide the practice of neonatologists, pediatric endocrinologists, general pediatricians, and pediatric surgeons. These guidelines cover a range of aspects, including general features of congenital hyperinsulinism, diagnostic criteria and tools for diagnosis, first- and second-line medical treatment, criteria for and details of surgical treatment, and future perspectives. These guidelines were generated as a collaborative effort between The Japanese Society for Pediatric Endocrinology and The Japanese Society of Pediatric Surgeons, and followed the official procedures of guideline generation to identify important clinical questions, perform a systematic literature review (April 2016), assess the evidence level of each paper, formulate the guidelines, and obtain public comments.

KW - Congenital hyperinsulinism

KW - Guidelines

KW - Hypoglycemia

UR - http://www.scopus.com/inward/record.url?scp=85026429035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026429035&partnerID=8YFLogxK

U2 - 10.1297/cpe.26.127

DO - 10.1297/cpe.26.127

M3 - Article

VL - 26

SP - 127

EP - 152

JO - Clinical Pediatric Endocrinology

JF - Clinical Pediatric Endocrinology

SN - 0918-5739

IS - 3

ER -